🔎 Trials Near Me

Utama › Gangguan Depresi Major › Virginia

Kajian klinikal Gangguan Depresi Major di Virginia

7 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi di Virginia.

Bandar di Virginia

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Richmond
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07105111

Evaluating Conversational Artificial Intelligence for Depression Management

  • George Mason University, Fairfax
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07105397

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Charlottesville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06911112

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Re:Cognition Health, Fairfax
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07412756

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Roanoke
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT07196501

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

  • Autobahn Site #145, Fairfax
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 20 Jan 2026 · NCT06633016

Study of ALTO-300 in MDD

  • Site 211, Roanoke
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Jul 2025 · NCT05922878

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.